The term penicillin tolerance, as described by Tomasz et al. (26) , refers to bacterial strains inhibited by penicillin in vitro but not killed by the usual bactericidal concentrations. This resistance has been related to defects in the bacterial autolytic enzyme system (25, 26) .
Several recent clinical reports attributed the failure of penicillin therapy in serious infections to the presence of tolerant bacteria; however, these retrospective analyses were uncontrolled, and the definition of tolerance used varied (17, 18, 22) . Therefore, the clinical relevance of this in vitro phenomenon remains uncertain (12) .
The purpose of this study was to compare the response to penicillin therapy of endocarditis in rabbits caused by a stable, well-characterized, tolerant bacterium with that caused by a similar, nontolerant organism. The strains used, a tolerant Streptococcus sanguis and a nontolerant Streptococcus mitis, are both viridans streptococci. The S. sanguis species is a common isolate in subacute bacterial endocarditis (14) and by in vitro testing appears to be naturally penicillin tolerant (9) (10) (11) . Despite this, penicillin treatment of endocarditis caused by this particular type of viridans streptococcus is considered highly effective. The strain (Wicky) chosen for this study has been described in several previously reported in vitro studies on tolerance (9) (10) (11) . Reports by Home and Tomasz (11) indicated that of nine S. sanguis strains tested, all were tolerant to penicillin. A nontolerant S. mitis strain with a minimal inhibitory concentration (MIC) for penicillin similar to that of the Wicky strain of S. sanguis was therefore chosen for comparison. S. mitis is also often associated with bacterial endocarditis (14) .
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MATERIALS AND METHODS
Bacterial strains. S. sanguis Wicky (kindly provided by A. Tomasz, Riockefeller University, New York, N.Y.) has been well characterized as a tolerant strain in previous in vitro studies (9) (10) (11) . Because attempts to identify a nontolerant strain of S. sanguis were unsuccessful, a closely related S. mitis strain was selected. The S. mitis strain used was a blood culture isolate obtained from a patient at Montefiore Hospital. Stock cultures of the two strains were prepared by freezing (-70°C) samples consisting of 0.5 ml of overnight growth of the organism in Todd-Hewitt broth (THB) and 0.5 ml of defibrinated sheep blood.
Antibiotic susceptibility tests. Broth dilution susceptibility testing was performed in duplicate in THB. An average initial bacterial inoculum of 5 x 10' colonyforming units (CFU)/ml, representing a 1:100 dilution of an overnight culture, was used. The MIC was interpreted by visual inspection after 24 h of incubation at 37°C. A 0.1-mi sample from each tube was subcultured onto sheep blood agar plates and incubated for an additional 48 h for measurement of the minimal bactericidal concentration (MBC). The MBC was recorded as that antibiotic concentration which resulted in 99.9o bacterial killing. MIC and MBC determinations were repeated on streptococcal isolates cultured from rabbit valvular vegetations after penicillin therapy for experimental endocarditis. Susceptibility testing was also performed as described above, with pooled, heat-inactivated rabbit serum rather than THB.
Time-kill studies. Time-kill studies were performed at 37°C with either a 1:10 or 1:200 dilution of an overnight growth of the S. sanguis or S. mitis strain in THB. The bacterial suspension was preincubated for 1.5 h before the penicillin was added (at a concentration of 2 or 20 ,ug/ml) to assure log-phase growvth. Portions were removed for colony counting at 0, 1, 2, 4, 6, 24, and 48 h and treated with Bacillus cereus betalactamase to minimize carry-over of penicillin activity (21) . Serial 10-fold dilutions were plated in duplicate into Todd-Hewitt agar. The plates were incubated for 48 h at 37C, and then the number of colonies was counted. The results represent the arithmetic mean of two separate studies.
Because of disparities observed between the MIC and MBC results and the time-kill studies, quantitative colony counts were performed on the clear tubes used in the broth dilution susceptibility studies that showed no growth after 24 h. Portions were removed from the clear tubes, serially diluted in saline, and plated in Todd-Hewitt agar containing beta-lactamase. The colonies were counted after 48 h of incubation at 3TC. These determinations were then compared with the data from the time-kill studies.
Rabbit model of e it Aortic valvular endocarditis was produced in male New Zealand rabbits (Penn Dutch Laboratory Animals, Denver, Pa.) by a modification of the method described by Perlman and Freedman (5, 15 Todd-Hewitt agar. The number of bacterial colonies was counted after 48 h of incubation at 37°C. At the conclusion of therapy, cardiac valvular vegetations were removed from the sacrificed rabbits 12 h after the 6th, 12th, or 18th dose. The vegetations were excised, weighed, homogenized in 1.0 ml of sterile saline, and plated in duplicate into Todd-Hewitt agar plates. Bacterial densities in valvular vegetations that were calculated to be between 0 and log1o 2 CFU/g were reported as loglo 2 CFU/g rather than as 0 because of potential errors associated with the low weight of the valvular tissue (4).
Penicllin serum levels. Serum antibiotic levels were obtained 0.5, 1, 3, 5, and 7 h after intramuscular injection and measured by a microbiological disk assay method with Sarcina lutea (21) . The highest penicillin serum levels were noted at 0.5 h. Standard solutions of penicillin were prepared in rabbit serum for controls. The results represent the arithmetic mean of at least 10 determinations per group.
Serum bacterkidal activity. Serum bactericidal levels were measured in the high-dose penicillin treatment groups. Rabbit serum was obtained 0.5 h after the intramuscular injection of penicillin on day 1 or 2 of therapy. The assays were performed as previously described (1) . Serial twofold dilutions of 0.5-ml samples of serum were made in THB. The S. sanguis strain was used to measure bactericidal activity in serum obtained from rabbits infected with S. sanguis, and the S. mitis strain was used for the rabbits infected with S. mitis. The bactericidal level was determined after 0.1-ml samples from each tube were streaked onto a sheep blood agar plate and incubated at 37°C for 48 h.
Pe r therapy experiments. Rabbits infected with either the S. sanguis or S. mitis strain were treated with penicillin for 2, 4, or 6 days. Both groups of infected rabbits were represented in each experiment. The animals were treated with procaine penicillin G (provided by Wyeth Laboratories, Philadelphia, Pa., and Eli Lilly & Co., Indianapolis, Ind.) administered intramuscuarly in a dosage of 5,000 or 80,000 U/kg every 8 h. The low-dose rpgimen was selected to achieve serum penicillin concentrations above the MIC but below the MBC of the tolerant S. sanguis strain. The high-dose regimen produced penicillin levels comparable to those commonly achieved in patients.
An additional experiment with a total of 22 rabbits was performed to determine whether a higher proportion of rabbits infected with one of the two bacterial species had positive valve cultures after 6 days of highdose procaine penicillin G treatment followed by an additional 5 days without therapy. The vegetations were excised and cultured as described above. Any rabbit that died during the 5 days after treatment was stopped was also evaluated for evidence of positive cardiac valve cultures.
Penillin prophylaxis experiments. Prophylaxis ex-68 LOWY ET AL. Time-kill studies. Two initial bacterial inocula were used. The first was the standard concentration of 5 x i05 CFU/ml, and the second was higher, 107 CFU/ml, to more closely approximate the bacterial density found in cardiac valvular tissue. At the standard inoculum, there was minimal killing (<1 log) over 24 h of the tolerant S. sanguis strain at a penicillin concentration of either 2 or 20 ,ug/ml (Fig. 1) . There was substantial killing of the nontolerant S. mitis strain, resulting in a greater than 3 log difference in survival between the two strains at both 24 and 48 h. Results were similar with the higher inoculum.
The MBC results suggested greater killing by a given concentration of penicillin (6.2 ,ug/ml) than did the killing curve results (<1 log killing with 20 ,ug/ml). This disparity was investigated by performing quantitative colony counts on samples removed from clear tubes after 24 h of incubation during the broth dilution susceptibility studies. Colony counts for S. sanguis were 2.9 x 104 CFU/ml in tubes containing 6.25 ,ug of penicillin per ml when the MBC by the standard tube dilution test method was 6.25 ,ug/ml. S. mitis had counts of 1.7 x 102 CFU/ml in the tube containing 0.05 ,ug of penicillin per ml when the MBC was 0.05 ,ug/ml. These studies showed that the two techniques provide different data for SMPCN ill serum levels. Serum penicillin concentrations for the high-dose regimen (80,000 U/kg) were 9.4 ± 6.3 and 2.5 ± 1.5 p/ml at 0.5 and 7 h, respectively, after intramuscular iWection. The 0.5-and 7-h levels for the low-dose regimen (5,000 U/kg) were 1.3 ± 0.4 and <0.1 pglml, respectively. There were no differences in penicillin levels between the groups of rabbits infected with each strain. Serum actiiy. Serum bacteriostatic tand bactericidal levels obtained with the high-dose regimen 0.5,h after intramuscular penicillin injection showed comparable bacteriostatic levels for both strains but a marked difference in bactericidal activity (Table 3) . Only minimal serum bactericidal activity was demonstrated against the tolerant strain. The ratio of serum bactericidal to bacteriostatic levels was comparablato the MBC/MIC ratios for the two strains.
1eniduin therpy ex ments. In the low-dose treatment group there was no difference in results for the tolerant and nontolerant strains after 2 or 4 days of penicillin therapy; however, there was a difference after 6 days ( Table 2 ). At that time, the bacterial densities in vegetations obtained from rabbits infected with the tolerant S. sanguis strain were significantly greater than those obtained from the nontolerant S. mitis strain (P < 0.001). There were no differences between the two groups when the high-dose penicillin regimen was used.
The results of broth dilution susceptibility studies performed on S. sanguis and S. mitis isolates (seven determinations per strain) obtained from valvular vegetations after penicillin therapy were unchanged.
An additional group of animals was treated with the high-dose regimen for 6 days and then observed for an additional 5 days to determine whether there was any difference in the proportion of positive valve cultures between rabbits infected with either strain. There were two of seven rabbits with positive cultures in the S. sanguis group (mean for the positive valve cultures, logl0 6.4 CFU/g), and one of eight was positive in the S. mitis group (logl0 2.6 CFU/g).
Penicillin prophylaxis experiments. A significant difference (P < 0.05) in valvular bacterial densities between the groups infected by the two strains was demonstrable only with the low-dose regimen (Table 4 ). There were no significant differences among groups which received the high-dose penicillin prophylaxis. The latter regimen was more effective in protecting the valves from seeding by either strain. There were no differences between the two groups in the number of sterile vegetations.
DISCUSSION
These results showed that penicillin therapy was less effective against the tolerant than the nontolerant streptococcus in the rabbit model of endocarditis only when the dose was severely limited., At the higher dose of penicillin, no differences were demonstrable in the prophylaxis or therapy studies despite the poor bactericidal activity obtained both in vivo and in vitro against the S. sanguis strain.
Ideally, two S. sanguis strains would have been compared, a tolerant versus a nontolerant strain. Attempts in our laboratory to identify a nontolerant S. sanguis strain were unsuccessful. Reports by Home and Tomasz (11) indicated that of nine strains tested, all were tolerant to penicillin. The S. mitis strain chosen was similar to the S. sanguis strain not only in the degree of susceptibility to growth inhibition by penicillin but also in biochemical characteristics (differing in fermentation of raffinose and arginine) (8) . In fact, it has been suggested, on the basis of these similarities and on DNA base sequence studies, that the S. mitis species be included in the type B S. sanguis biotype (8) . Clinically, both strains produce comparable forms of endocarditis, with a similar incidence of complications and response to antibiotic therapy (14) .
In the present study both organisms consistently produced ultimately fatal endocarditis with similar initial cardiac valvular bacterial densities in rabbits. However, S. mitis produced a higher initial mortality and a higher level of bacteremia. Despite this suggestion of greater virulence for the S. mitis strain, it was more effectively treated by the low dose of penicillin.
The response to penicillin for both strains was consistent in the in vitro time-kill studies and in the serum bactericidal studies performed on samples taken from rabbits being treated for endocarditis at a time when the serum penicillin levels averaged 9.4 jjwg/ml. The nontolerant S. mitis strain was readily killed by penicillin concentrations of 2 ,g/ml in vitro, and median serum bactericidal levels against it were 1/64. In contrast, the tolerant S. sanguis strain showed little killing by penicillin concentrations of 20 i.g/ml in vitro, and minimal serum bactericidal activity (<1/2) was developed against it. In addition, there was no change in MIC and MBC results in bacterial isolates obtained from vegetations of penicillin-treated animals.
S. sanguis appears to be a naturally occurring tolerant species (9-11). Home and Tomasz (11) studied nine strains of S. sanguis, including five obtained from patients with endocarditis, and found that all were penicillin tolerant in vitro. These strains were resistant to the bactericidal activity of penicillin unless they were first exposed to exogenous autolysin (11) . It is of interest that S. sanguis is among the most common isolates from patients with viridans streptococcal endocarditis, an infection in which the use of bactericidal antibiotics such as penicillin in therapy generally achieves cure (14, 24) .
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poorly responsive to penicillin therapy and caused by tolerant bacteria have been those due to staphylococci, although group C and nonenterococcal group D streptococci have also been cited (17, 18, 22, 23) . Such studies are difficult to interpret because they involve small numbers of retrospectively analyzed clinical cases in which therapy as well as definitions of tolerance have varied. In only one study was tolerance correlated with a decrease in autolytic activity in the isolates (22) . In addition, penicillin tolerance in staphylococci is manifested differently than it is in S. sanguis. Results for staphylococci are not reliably reproducible in vitro, and the tolerance mechanism is less clearly understood (2, 3, 13, 16, 19) . These problems have all contributed to the confusion about the clinical importance of tolerance (12, 20) . Goldman and Petersdorf (6) compared the response to methicillin therapy of single strains of tolerant and nontolerant Staphylococcus aureus in the rabbit endocarditis model. No differences between the two strains were found in this model in either response to treatment with or prevention of an experimental infection by pharmacological doses of methicillin. Similar results were reported by Guze et al. (7), who compared the response of tolerant and nontolerant staphylococci to methicillin therapy in a rat model of hematogenous pyelonephritis. In neither study was tolerance documented with serum bactericidal titers. These studies are difficult to interpret because of the inconsistency of tolerance often shown by staphylococci in vitro (2, 13, 16) .
The present study investigated tolerance by using a well-characterized, stable, tolerant viridans streptococcus and compared the results with those for a similar nontolerant organism.
Our data indicated that there were no differences in the response to penicillin therapy for experimental endocarditis between the two groups with the high-dose penicillin regimen, despite the differences in serum bactericidal activity. In the studies investigating the frequency of bacteriological relapse, it was of interest that the bacterial densities in the S. sanguis group were higher in the few rabbits with positive cultures.
However, the overall results of our studies suggest the possibility that factors other than bactericidal antibiotic activity may have an important role in eradicating infection in this animal model. The nonlethal activity of penicillin may have an important effect on bacteria-host tissue interactions (11) . In addition, response to therapy may occur as a result of the slow, gradual bacterial killing by penicillin per se over a prolonged time period that may occur even with tolerant bactena.
Although it is unlikely that a clinical situation would arise in which penicillin would now be used in a dosage comparable to that used for the low-dose group in the present treatment study, the low-dose situation might arise during antibiotic prophylaxis for endocarditis before dental procedures are performed. In this setting a tolerant S. sanguis strain might be more capable of colonizing a valvular vegetation and producing endocarditis than a comparable nontolerant strain. This possibility is suggested by the study on prophylaxis with the low dose of penicillin reported here.
